Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 2
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle.
Di Ruscio V, Del Baldo G, Fabozzi F, Vinci M, Cacchione A, de Billy E, Megaro G, Carai A, Mastronuzzi A. Di Ruscio V, et al. Diagnostics (Basel). 2022 Aug 25;12(9):2064. doi: 10.3390/diagnostics12092064. Diagnostics (Basel). 2022. PMID: 36140466 Free PMC article. Review.
Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience.
Del Baldo G, Carai A, Abbas R, Cacchione A, Vinci M, Di Ruscio V, Colafati GS, Rossi S, Diomedi Camassei F, Maestro N, Temelso S, Pericoli G, De Billy E, Giovannoni I, Carboni A, Rinelli M, Agolini E, Mackay A, Jones C, Chiesa S, Balducci M, Locatelli F, Mastronuzzi A. Del Baldo G, et al. Among authors: di ruscio v. Ther Adv Med Oncol. 2022 Sep 6;14:17588359221113693. doi: 10.1177/17588359221113693. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36090803 Free PMC article.
Intrathoracic synovial sarcoma with BRAF V600E mutation.
Russo I, Barresi S, Di Paolo PL, Di Ruscio V, Del Baldo G, Serra A, Vallese S, Miele E, Mastronuzzi A, Alaggio R, Ferrari A, Milano GM. Russo I, et al. Among authors: di ruscio v. Oncotarget. 2023 Jul 7;14:703-708. doi: 10.18632/oncotarget.28475. Oncotarget. 2023. PMID: 37417899 Free PMC article.
Frequency and characterization of cognitive impairments in patients diagnosed with paediatric central nervous system tumours: a systematic review.
Sciancalepore F, Fabozzi F, Albino G, Del Baldo G, Di Ruscio V, Laus B, Menegatti D, Premuselli R, Secco DE, Tozzi AE, Lacorte E, Vanacore N, Carai A, Mastronuzzi A; Allena-Mente Study Group. Sciancalepore F, et al. Among authors: di ruscio v. Front Oncol. 2023 May 19;13:1198521. doi: 10.3389/fonc.2023.1198521. eCollection 2023. Front Oncol. 2023. PMID: 37274224 Free PMC article. Review.
Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
Patrizi S, Miele E, Falcone L, Vallese S, Rossi S, Barresi S, Giovannoni I, Pedace L, Nardini C, Masier I, Abballe L, Cacchione A, Russo I, Di Giannatale A, Di Ruscio V, Salgado CM, Mastronuzzi A, Ciolfi A, Tartaglia M, Milano GM, Locatelli F, Alaggio R. Patrizi S, et al. Among authors: di ruscio v. Clin Epigenetics. 2024 Jan 4;16(1):9. doi: 10.1186/s13148-023-01621-7. Clin Epigenetics. 2024. PMID: 38178234 Free PMC article.
Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience.
Di Ruscio V, Carai A, Del Baldo G, Vinci M, Cacchione A, Miele E, Rossi S, Antonelli M, Barresi S, Caulo M, Colafati GS, Mastronuzzi A. Di Ruscio V, et al. Diagnostics (Basel). 2022 Feb 1;12(2):372. doi: 10.3390/diagnostics12020372. Diagnostics (Basel). 2022. PMID: 35204463 Free PMC article.
Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma.
Vinti L, Pagliara D, Buffardi S, Di Ruscio V, Stocchi F, Mariggiò E, Parasole R, Di Matteo A, Petruzziello F, Paganelli V, De Vito R, Del Bufalo F, Strocchio L, Locatelli F. Vinti L, et al. Among authors: di ruscio v. Pediatr Blood Cancer. 2022 Apr;69(4):e29557. doi: 10.1002/pbc.29557. Epub 2022 Feb 2. Pediatr Blood Cancer. 2022. PMID: 35107876
Long-term response to crizotinib in a 17-year-old boy with treatment-naïve ALK-positive non-small-cell lung cancer.
Megaro G, Miele E, Spinelli GP, Alessi I, Del Baldo G, Cozza R, Russo I, De Pasquale MD, Cefalo MG, Tomà P, Carai A, Di Ruscio V, De Ioris MA, Mastronuzzi A. Megaro G, et al. Among authors: di ruscio v. Cancer Rep (Hoboken). 2022 Mar;5(3):e1483. doi: 10.1002/cnr2.1483. Epub 2022 Jan 28. Cancer Rep (Hoboken). 2022. PMID: 35092185 Free PMC article.
16 results